Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

The FDA has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent (dupilumab), in patients aged 12 years...
The new Centre for Protein Degradation has been launched, made possible by a £9 million donation to The Institute of Cancer Research, London (ICR)....
Parents and carers of five to 11-year olds in England can now book a low-dose COVID-19 vaccine for their children. The jabs can be booked online and...
NICE has published further draft guidance for public consultation which does not recommend icosapent ethyl for reducing the risk of cardiovascular...
UCB has announced that FINTEPLA® (fenfluramine) oral solution CIV has been approved by the FDA for the treatment of seizures associated with Lennox-...
CSL Behring has today announced that the EMA has accepted the Marketing Authorising Application for etranacogene dezaparvovec (EtranaDez), under its...
A life-saving blood test that can help diagnose suspected preterm pre-eclampsia has been recommended by NICE, and this is to benefit many pregnant...
The FDA has approved Bristol-Myers Squibb’s Opdualag (nivolumab and relatlimab-rmbw), the first drug in a new class of cancer immunotherapies, as an...
Those aged 75 and over, alongside residents in care homes and those with weakened immune systems, can now book an extra COVID-19 booster jab in...
The National Institute of Mental Health has renewed its support for UCLA’s collaborative Centre for HIV Identification, Prevention and Treatment...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches